Patents by Inventor Vivek Rangnekar

Vivek Rangnekar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylquinoline and analog compounds and use thereof to treat cancer
    Patent number: 9873670
    Abstract: The subject technology relates to arylquinoline compounds and their use for treating cancer or cancer metastasis. The compounds of the subject technology promote cells to secrete a pro-apoptotic tumor suppressor, i.e., prostate apoptosis response-4 (Par-4), which in turn promote apoptosis in cancer cells or metastatic cells.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: January 23, 2018
    Assignee: University of Kentucky Research Foundation
    Inventors: David S. Watt, Chunming Liu, Vivek Rangnekar, Vitaliy M. Sviripa, Ravshan Burikhanov, Wen Zhang
  • ARYLQUINOLINE AND ANALOG COMPOUNDS AND USE THEREOF TO TREAT CANCER
    Publication number: 20160280652
    Abstract: The subject technology relates to arylquinoline compounds and their use for treating cancer or cancer metastasis. The compounds of the subject technology promote cells to secrete a pro-apoptotic tumor suppressor, i.e., prostate apoptosis response-4 (Par-4), which in turn promote apoptosis in cancer cells or metastatic cells.
    Type: Application
    Filed: November 21, 2014
    Publication date: September 29, 2016
    Inventors: David S. WATT, Chunming LIU, Vivek RANGNEKAR, Vitaliy M. SVIRIPA, Ravshan BURIKHANOV, Wen ZHANG
  • Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells
    Publication number: 20050118179
    Abstract: The present invention relates to Par-4 mutants which cause apoptosis in cancer cells which are sensitive to Par-4 and also induce apoptosis in cancer cells which are resistant to Par-4. The present invention also relates to methods of using the Par-4 mutant to treat certain cancers, as well as to kits, vectors, and polypeptides for same.
    Type: Application
    Filed: December 4, 2003
    Publication date: June 2, 2005
    Applicant: University of Kentucky Research Foundation
    Inventor: Vivek Rangnekar